img

Global and United States Monoclonal Antibody Medicine Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Monoclonal Antibody Medicine Market Report & Forecast 2024-2034

Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
Market Analysis and InsightsGlobal and United States Monoclonal Antibody Medicine Market
This report focuses on global and United States Monoclonal Antibody Medicine market, also covers the segmentation data of other regions in regional level and county level.
The global Monoclonal Antibody Medicine revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In United States the Monoclonal Antibody Medicine revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Monoclonal Antibody Medicine include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis and Merck, etc. The global five biggest players hold a share of % in 2024.
Global Monoclonal Antibody Medicine Scope and Market Size
Monoclonal Antibody Medicine market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Monoclonal Antibody Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the Monoclonal Antibody Medicine market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Innovent Biologics
Segment by Type
Biologics
Biosimilars

Segment by Application


Cancer
Autoimmune Disease
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Monoclonal Antibody Medicine definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Monoclonal Antibody Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Monoclonal Antibody Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Monoclonal Antibody Medicine revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Monoclonal Antibody Medicine Product Introduction
1.2 Global Monoclonal Antibody Medicine Outlook 2018 VS 2024 VS 2034
1.2.1 Global Monoclonal Antibody Medicine Market Size for the Year 2018-2034
1.2.2 United States Monoclonal Antibody Medicine Market Size for the Year 2018-2034
1.3 Monoclonal Antibody Medicine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Monoclonal Antibody Medicine in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Monoclonal Antibody Medicine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Monoclonal Antibody Medicine Market Dynamics
1.4.1 Monoclonal Antibody Medicine Industry Trends
1.4.2 Monoclonal Antibody Medicine Market Drivers
1.4.3 Monoclonal Antibody Medicine Market Challenges
1.4.4 Monoclonal Antibody Medicine Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Monoclonal Antibody Medicine by Type
2.1 Monoclonal Antibody Medicine Market Segment by Type
2.1.1 Biologics
2.1.2 Biosimilars
2.2 Global Monoclonal Antibody Medicine Market Size by Type (2018, 2024 & 2034)
2.3 Global Monoclonal Antibody Medicine Market Size by Type (2018-2034)
2.4 United States Monoclonal Antibody Medicine Market Size by Type (2018, 2024 & 2034)
2.5 United States Monoclonal Antibody Medicine Market Size by Type (2018-2034)
3 Monoclonal Antibody Medicine by Application
3.1 Monoclonal Antibody Medicine Market Segment by Application
3.1.1 Cancer
3.1.2 Autoimmune Disease
3.1.3 Other
3.2 Global Monoclonal Antibody Medicine Market Size by Application (2018, 2024 & 2034)
3.3 Global Monoclonal Antibody Medicine Market Size by Application (2018-2034)
3.4 United States Monoclonal Antibody Medicine Market Size by Application (2018, 2024 & 2034)
3.5 United States Monoclonal Antibody Medicine Market Size by Application (2018-2034)
4 Global Monoclonal Antibody Medicine Competitor Landscape by Company
4.1 Global Monoclonal Antibody Medicine Market Size by Company
4.1.1 Global Key Companies of Monoclonal Antibody Medicine, Ranked by Revenue (2024)
4.1.2 Global Monoclonal Antibody Medicine Revenue by Player (2018-2023)
4.2 Global Monoclonal Antibody Medicine Concentration Ratio (CR)
4.2.1 Monoclonal Antibody Medicine Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Monoclonal Antibody Medicine in 2024
4.2.3 Global Monoclonal Antibody Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Monoclonal Antibody Medicine Head office and Area Served
4.4 Global Key Players of Monoclonal Antibody Medicine, Product and Application
4.5 Global Key Players of Monoclonal Antibody Medicine, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Monoclonal Antibody Medicine Market Size by Company
4.7.1 Key Players of Monoclonal Antibody Medicine in United States, Ranked by Revenue (2024)
4.7.2 United States Monoclonal Antibody Medicine Revenue by Players (2021, 2024 & 2023)
5 Global Monoclonal Antibody Medicine Market Size by Region
5.1 Global Monoclonal Antibody Medicine Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Monoclonal Antibody Medicine Market Size by Region (2018-2034)
5.2.1 Global Monoclonal Antibody Medicine Market Size by Region: 2018-2023
5.2.2 Global Monoclonal Antibody Medicine Market Size by Region (2024-2034)
6 Americas
6.1 Americas Monoclonal Antibody Medicine Market Size YoY Growth 2018-2034
6.2 Americas Monoclonal Antibody Medicine Market Size by Type
6.2.1 Americas Monoclonal Antibody Medicine Market Size by Type (2018-2023)
6.2.2 Americas Monoclonal Antibody Medicine Market Size by Type (2024-2034)
6.2.3 Americas Monoclonal Antibody Medicine Market Share by Type (2018-2034)
6.3 Americas Monoclonal Antibody Medicine Market Size by Application
6.3.1 Americas Monoclonal Antibody Medicine Market Size by Application (2018-2023)
6.3.2 Americas Monoclonal Antibody Medicine Market Size by Application (2024-2034)
6.3.3 Americas Monoclonal Antibody Medicine Market Share by Application (2018-2034)
6.4 Americas Monoclonal Antibody Medicine Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Monoclonal Antibody Medicine Market Size YoY Growth 2018-2034
7.2 EMEA Monoclonal Antibody Medicine Market Size by Type
7.2.1 EMEA Monoclonal Antibody Medicine Market Size by Type (2018-2023)
7.2.2 EMEA Monoclonal Antibody Medicine Market Size by Type (2024-2034)
7.2.3 EMEA Monoclonal Antibody Medicine Market Share by Type (2018-2034)
7.3 EMEA Monoclonal Antibody Medicine Market Size by Application
7.3.1 EMEA Monoclonal Antibody Medicine Market Size by Application (2018-2023)
7.3.2 EMEA Monoclonal Antibody Medicine Market Size by Application (2024-2034)
7.3.3 EMEA Monoclonal Antibody Medicine Market Share by Application (2018-2034)
7.4 EMEA Monoclonal Antibody Medicine Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Monoclonal Antibody Medicine Market Size YoY Growth 2018-2034
8.2 China Monoclonal Antibody Medicine Market Size by Type
8.2.1 China Monoclonal Antibody Medicine Market Size by Type (2018-2023)
8.2.2 China Monoclonal Antibody Medicine Market Size by Type (2024-2034)
8.2.3 China Monoclonal Antibody Medicine Market Share by Type (2018-2034)
8.3 China Monoclonal Antibody Medicine Market Size by Application
8.3.1 China Monoclonal Antibody Medicine Market Size by Application (2018-2023)
8.3.2 China Monoclonal Antibody Medicine Market Size by Application (2024-2034)
8.3.3 China Monoclonal Antibody Medicine Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Monoclonal Antibody Medicine Market Size YoY Growth 2018-2034
9.2 APAC Monoclonal Antibody Medicine Market Size by Type
9.2.1 APAC Monoclonal Antibody Medicine Market Size by Type (2018-2023)
9.2.2 APAC Monoclonal Antibody Medicine Market Size by Type (2024-2034)
9.2.3 APAC Monoclonal Antibody Medicine Market Share by Type (2018-2034)
9.3 APAC Monoclonal Antibody Medicine Market Size by Application
9.3.1 APAC Monoclonal Antibody Medicine Market Size by Application (2018-2023)
9.3.2 APAC Monoclonal Antibody Medicine Market Size by Application (2024-2034)
9.3.3 APAC Monoclonal Antibody Medicine Market Share by Application (2018-2034)
9.4 APAC Monoclonal Antibody Medicine Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Roche
10.1.1 Roche Company Details
10.1.2 Roche Business Overview
10.1.3 Roche Monoclonal Antibody Medicine Introduction
10.1.4 Roche Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.1.5 Roche Recent Development
10.2 Amgen
10.2.1 Amgen Company Details
10.2.2 Amgen Business Overview
10.2.3 Amgen Monoclonal Antibody Medicine Introduction
10.2.4 Amgen Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.2.5 Amgen Recent Development
10.3 AbbVie
10.3.1 AbbVie Company Details
10.3.2 AbbVie Business Overview
10.3.3 AbbVie Monoclonal Antibody Medicine Introduction
10.3.4 AbbVie Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.3.5 AbbVie Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Details
10.4.2 Sanofi Business Overview
10.4.3 Sanofi Monoclonal Antibody Medicine Introduction
10.4.4 Sanofi Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.4.5 Sanofi Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Details
10.5.2 Johnson & Johnson Business Overview
10.5.3 Johnson & Johnson Monoclonal Antibody Medicine Introduction
10.5.4 Johnson & Johnson Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.5.5 Johnson & Johnson Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Details
10.6.2 Pfizer Business Overview
10.6.3 Pfizer Monoclonal Antibody Medicine Introduction
10.6.4 Pfizer Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.6.5 Pfizer Recent Development
10.7 Eli Lilly
10.7.1 Eli Lilly Company Details
10.7.2 Eli Lilly Business Overview
10.7.3 Eli Lilly Monoclonal Antibody Medicine Introduction
10.7.4 Eli Lilly Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.7.5 Eli Lilly Recent Development
10.8 Novartis
10.8.1 Novartis Company Details
10.8.2 Novartis Business Overview
10.8.3 Novartis Monoclonal Antibody Medicine Introduction
10.8.4 Novartis Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.8.5 Novartis Recent Development
10.9 Merck
10.9.1 Merck Company Details
10.9.2 Merck Business Overview
10.9.3 Merck Monoclonal Antibody Medicine Introduction
10.9.4 Merck Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.9.5 Merck Recent Development
10.10 Biogen
10.10.1 Biogen Company Details
10.10.2 Biogen Business Overview
10.10.3 Biogen Monoclonal Antibody Medicine Introduction
10.10.4 Biogen Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.10.5 Biogen Recent Development
10.11 Celltrion
10.11.1 Celltrion Company Details
10.11.2 Celltrion Business Overview
10.11.3 Celltrion Monoclonal Antibody Medicine Introduction
10.11.4 Celltrion Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.11.5 Celltrion Recent Development
10.12 Sobi
10.12.1 Sobi Company Details
10.12.2 Sobi Business Overview
10.12.3 Sobi Monoclonal Antibody Medicine Introduction
10.12.4 Sobi Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.12.5 Sobi Recent Development
10.13 3SBIO
10.13.1 3SBIO Company Details
10.13.2 3SBIO Business Overview
10.13.3 3SBIO Monoclonal Antibody Medicine Introduction
10.13.4 3SBIO Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.13.5 3SBIO Recent Development
10.14 Innovent Biologics
10.14.1 Innovent Biologics Company Details
10.14.2 Innovent Biologics Business Overview
10.14.3 Innovent Biologics Monoclonal Antibody Medicine Introduction
10.14.4 Innovent Biologics Revenue in Monoclonal Antibody Medicine Business (2018-2023)
10.14.5 Innovent Biologics Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Monoclonal Antibody Medicine Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Monoclonal Antibody Medicine Market Trends
Table 3. Monoclonal Antibody Medicine Market Drivers
Table 4. Monoclonal Antibody Medicine Market Challenges
Table 5. Monoclonal Antibody Medicine Market Restraints
Table 6. Global Monoclonal Antibody Medicine Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Monoclonal Antibody Medicine Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Monoclonal Antibody Medicine Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Monoclonal Antibody Medicine Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Monoclonal Antibody Medicine, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Monoclonal Antibody Medicine Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Monoclonal Antibody Medicine Revenue Share by Player, 2018-2023
Table 13. Global Monoclonal Antibody Medicine Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monoclonal Antibody Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Medicine as of 2024)
Table 15. Global Key Players of Monoclonal Antibody Medicine, Headquarters and Area Served
Table 16. Global Key Players of Monoclonal Antibody Medicine, Product and Application
Table 17. Global Key Players of Monoclonal Antibody Medicine, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Monoclonal Antibody Medicine in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Monoclonal Antibody Medicine Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Monoclonal Antibody Medicine Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Monoclonal Antibody Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Monoclonal Antibody Medicine Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Monoclonal Antibody Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Monoclonal Antibody Medicine Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Monoclonal Antibody Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Monoclonal Antibody Medicine Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Monoclonal Antibody Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Monoclonal Antibody Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Monoclonal Antibody Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Monoclonal Antibody Medicine Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Monoclonal Antibody Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Monoclonal Antibody Medicine Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Monoclonal Antibody Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Monoclonal Antibody Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Monoclonal Antibody Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Monoclonal Antibody Medicine Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Monoclonal Antibody Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Monoclonal Antibody Medicine Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Monoclonal Antibody Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Monoclonal Antibody Medicine Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Monoclonal Antibody Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Monoclonal Antibody Medicine Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Monoclonal Antibody Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Monoclonal Antibody Medicine Market Size by Region (2024-2034) & (US$ Million)
Table 51. Roche Company Details
Table 52. Roche Business Overview
Table 53. Roche Monoclonal Antibody Medicine Product
Table 54. Roche Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Amgen Company Details
Table 57. Amgen Business Overview
Table 58. Amgen Monoclonal Antibody Medicine Product
Table 59. Amgen Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 60. Amgen Recent Development
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Monoclonal Antibody Medicine Product
Table 64. AbbVie Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Monoclonal Antibody Medicine Product
Table 69. Sanofi Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Monoclonal Antibody Medicine Product
Table 74. Johnson & Johnson Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Monoclonal Antibody Medicine Product
Table 79. Pfizer Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Eli Lilly Company Details
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Monoclonal Antibody Medicine Product
Table 84. Eli Lilly Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 85. Eli Lilly Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Monoclonal Antibody Medicine Product
Table 89. Novartis Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Monoclonal Antibody Medicine Product
Table 94. Merck Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Biogen Company Details
Table 97. Biogen Business Overview
Table 98. Biogen Monoclonal Antibody Medicine Product
Table 99. Biogen Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 100. Biogen Recent Development
Table 101. Celltrion Company Details
Table 102. Celltrion Business Overview
Table 103. Celltrion Monoclonal Antibody Medicine Product
Table 104. Celltrion Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 105. Celltrion Recent Development
Table 106. Sobi Company Details
Table 107. Sobi Business Overview
Table 108. Sobi Monoclonal Antibody Medicine Product
Table 109. Sobi Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 110. Sobi Recent Development
Table 111. 3SBIO Company Details
Table 112. 3SBIO Business Overview
Table 113. 3SBIO Monoclonal Antibody Medicine Product
Table 114. 3SBIO Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 115. 3SBIO Recent Development
Table 116. Innovent Biologics Company Details
Table 117. Innovent Biologics Business Overview
Table 118. Innovent Biologics Monoclonal Antibody Medicine Product
Table 119. Innovent Biologics Revenue in Monoclonal Antibody Medicine Business (2018-2023) & (US$ Million)
Table 120. Innovent Biologics Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibody Medicine Product Picture
Figure 2. Global Monoclonal Antibody Medicine Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Monoclonal Antibody Medicine Market Size 2018-2034 (US$ Million)
Figure 4. United States Monoclonal Antibody Medicine Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Monoclonal Antibody Medicine Market Size 2018-2034 (US$ Million)
Figure 6. United States Monoclonal Antibody Medicine Market Share in Global 2018-2034
Figure 7. Monoclonal Antibody Medicine Report Years Considered
Figure 8. Product Picture of Biologics
Figure 9. Product Picture of Biosimilars
Figure 10. Global Monoclonal Antibody Medicine Market Share by Type in 2024 & 2034
Figure 11. Global Monoclonal Antibody Medicine Market Size by Type (2018-2034) & (US$ Million)
Figure 12. Global Monoclonal Antibody Medicine Market Share by Type (2018-2034)
Figure 13. United States Monoclonal Antibody Medicine Market Share by Type in 2024 & 2034
Figure 14. United States Monoclonal Antibody Medicine Market Size by Type (2018-2034) & (US$ Million)
Figure 15. United States Monoclonal Antibody Medicine Market Share by Type (2018-2034)
Figure 16. Product Picture of Cancer
Figure 17. Product Picture of Autoimmune Disease
Figure 18. Product Picture of Other
Figure 19. Global Monoclonal Antibody Medicine Market Share by Application in 2024 & 2034
Figure 20. Global Monoclonal Antibody Medicine Market Size by Application (2018-2034) & (US$ Million)
Figure 21. Global Monoclonal Antibody Medicine Market Share by Application (2018-2034)
Figure 22. United States Monoclonal Antibody Medicine Market Share by Application in 2024 & 2034
Figure 23. United States Monoclonal Antibody Medicine Market Size by Application (2018-2034) & (US$ Million)
Figure 24. United States Monoclonal Antibody Medicine Market Share by Application (2018-2034)
Figure 25. The Top 5 and 10 Largest Companies of Monoclonal Antibody Medicine in the World: Market Share by Monoclonal Antibody Medicine Revenue in 2024
Figure 26. Global Monoclonal Antibody Medicine Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 27. Global Monoclonal Antibody Medicine Market Share by Region (2018-2034)
Figure 28. Americas Monoclonal Antibody Medicine Market Size Growth Rate 2018-2034 (US$ Million)
Figure 29. Americas Monoclonal Antibody Medicine Market Share by Type (2018-2034)
Figure 30. Americas Monoclonal Antibody Medicine Market Share by Application (2018-2034)
Figure 31. United States Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 32. Canada Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 33. Mexico Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. Brazil Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. EMEA Monoclonal Antibody Medicine Market Size Growth Rate 2018-2034 (US$ Million)
Figure 36. EMEA Monoclonal Antibody Medicine Market Share by Type (2018-2034)
Figure 37. EMEA Monoclonal Antibody Medicine Market Share by Application (2018-2034)
Figure 38. Europe Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 39. Middle East Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 40. Africa Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 41. China Monoclonal Antibody Medicine Market Size Growth Rate 2018-2034 (US$ Million)
Figure 42. China Monoclonal Antibody Medicine Market Share by Type (2018-2034)
Figure 43. China Monoclonal Antibody Medicine Market Share by Application (2018-2034)
Figure 44. APAC Monoclonal Antibody Medicine Market Size Growth Rate 2018-2034 (US$ Million)
Figure 45. APAC Monoclonal Antibody Medicine Market Share by Type (2018-2034)
Figure 46. APAC Monoclonal Antibody Medicine Market Share by Application (2018-2034)
Figure 47. Japan Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 48. South Korea Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 49. China Taiwan Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. Southeast Asia Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. India Monoclonal Antibody Medicine Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. Roche Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 53. Amgen Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 54. AbbVie Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 55. Sanofi Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 56. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 58. Eli Lilly Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 59. Novartis Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 60. Merck Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 61. Biogen Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 62. Celltrion Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 63. Sobi Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 64. 3SBIO Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 65. Innovent Biologics Revenue Growth Rate in Monoclonal Antibody Medicine Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed